What is Spravato®?
An FDA-approved nasal spray therapy used alongside an oral antidepressant for treatment-resistant depression.

SPRAVATO
Spravato® (esketamine) is an FDA-approved nasal spray treatment for adults with treatment-resistant depression. When traditional antidepressants haven't been enough, Spravato® can offer real, often rapid relief — delivered in a calm, semi-private suite with compassionate monitoring at every step.
An FDA-approved nasal spray therapy used alongside an oral antidepressant for treatment-resistant depression.
It works on glutamate pathways — a different mechanism than traditional antidepressants — which is why it often works when others haven't.
You're cared for in a private suite — warm lighting, a soft blanket, and one-on-one support throughout your visit.
Is it right for me?
Spravato® isn't the first step for everyone, but for people who've tried antidepressants without lasting relief, it can be life-changing. We'll walk through this together at your consultation — no pressure, just honest guidance.
How treatment works
A guided, gentle process — at every step you'll know what comes next.
We talk through your history and goals to see if Spravato® is right for you.
Our team handles the prior authorization paperwork on your behalf.
You'll relax in a semi-private suite with blankets for your comfort.
You'll rest for two hours of compassionate monitoring before heading home.
We continue supporting your journey with regular check-ins.

Our Space
Page Health Services is a Spravato® REMS-certified facility. We have four comfortable Spravato® suites where you can recline, rest, and relax during the required monitoring period.
Each treatment session includes two hours of monitoring, and you'll need a designated ride home. Feel free to bring personal devices, headphones, water, or anything else that helps make your monitoring time even more comfortable.
What your visit feels like
Benefits
Beyond the treatment itself, the experience matters. Every detail of our suites is built to help you feel safe, supported, and unhurried — from the lighting to the blanket on your lap.
A patient's story
“Kristy is an amazing human. I struggled with finding a provider that I clicked with & felt that actually hear me. She was able to get my meds adjusted & after a year of seeing her I started Spravato. It has been such a life changing experience. The office is a warm, welcoming environment. There are multiple rooms with different light levels. The chairs are comfy. A little 2 hour nap or jam session to some Tash Sultana is the best part of my week. Thanks so much for all of your help!”
Individual results vary. Patient name and location changed to protect privacy; story shared with permission.
Spravato® FAQs
Spravato® (esketamine) is an FDA-approved nasal spray, used together with an oral antidepressant, to treat adults with treatment-resistant depression. It works differently from traditional antidepressants by targeting the brain's NMDA receptors — which is why it can help when other medications haven't.
Most antidepressants take 4–8 weeks to take effect and work on serotonin pathways. Spravato® works on glutamate signaling and can begin to lift symptoms within days to weeks for many patients. You'll continue your oral antidepressant alongside Spravato® for the best results.
You may nap or you may remain awake but very relaxed. Some patients describe a dreamlike or floating state. Our staff monitors you throughout your treatment session.
Spravato® is FDA-approved and only administered in certified treatment centers under the REMS safety program. We monitor your blood pressure and well-being throughout the two-hour visit.
No. You'll need a friend, family member, or rideshare to drive you home after each session. Plan to rest the remainder of the day.
Plan for about 2 hours: a short intake and dosing, then a quiet recovery period before you leave. Sessions are typically twice a week at first, then taper down.
Many major insurance plans cover Spravato®. We handle prior authorization and walk you through your specific benefits before you commit.
The most common are temporary dissociation, mild dizziness, nausea, or a brief rise in blood pressure — all of which typically resolve during your recovery period. We'll review the full safety profile at your consultation.
Have a question we didn't cover? Visit our general FAQs or send us a message — we're happy to help.
Explore medication management, GeneSight, and primary care.
Learn more →Learn about the provider guiding your care.
Learn more →Insurance, scheduling, and what to expect.
Learn more →Send a request and we'll reach out within one business day.
Learn more →A short conversation is all it takes to find out if Spravato® may be right for you.